Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Biomarker driven clinical trials

Share :

SABCS 2015

8 - 12 Dec 2015
Published: 20 Dec 2016
Views: 2106
Rating:
Save
Dr Oleg Gluz - West German Study Group Monchengladbach, Germany

Dr Gluz talks to ecancertv at SABCS 2015 about biomarker driven clinical trials and the WSG-ADAPT TN randomised phase II trial.

WSG-ADAPT TN is an adjuvant dynamic marker-adjusted personalised therapy trial, optimising risk assessment and therapy response prediction in early breast cancer.

Related Videos

Breast and emerging indications for IORT
Dr David Martinez Perez - AUNA, Lima, Peru
Breast and emerging indications for IORT ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023
The advantages of IORT for early breast cancer treatment
Dr David Martinez Perez - AUNA, Lima, Peru
The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023
The pros and cons of breast IORT and ultra hypofractionation (FR)
Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France
The pros and cons of breast IORT and ultra hypofractionation (FR) ( Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France )
4 Apr 2023
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
28 Mar 2023
Global adoption of single-shot targeted IORT for breast cancer
Dr Jayant Vaidya - University College London, London, UK
Global adoption of single-shot targeted IORT for breast cancer ( Dr Jayant Vaidya - University College London, London, UK )
9 Mar 2023
IORT at the Asian Hospital and Medical Center
Dr Aldine Basa - Asian Hospital and Medical Center, Manila, Philippines
IORT at the Asian Hospital and Medical Center ( Dr Aldine Basa - Asian Hospital and Medical Center, Manila, Philippines )
9 Mar 2023
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation...
Dr Jayant Vaidya - University College London, London, UK
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival ( Dr Jayant Vaidya - University College London, London, UK )
9 Mar 2023
Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast...
Dr Jayant Vaidya - University College London, London, UK
Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer ( Dr Jayant Vaidya - University College London, London, UK )
9 Mar 2023
The advancements in radiotherapy for breast cancer patients
Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia
The advancements in radiotherapy for breast cancer patients ( Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia )
1 Feb 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation